Total Payments
$86,185
2024 Payments
$681.55
Companies
26
Transactions
130
Medicare Patients
1,371
Medicare Billing
$329,443
Payment Breakdown by Category
Research$73,626 (85.4%)
Other$7,030 (8.2%)
Food & Beverage$2,857 (3.3%)
Consulting$2,115 (2.5%)
Education$374.60 (0.4%)
Travel$182.92 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $73,626 | 11 | 85.4% |
| Honoraria | $7,030 | 6 | 8.2% |
| Food and Beverage | $2,857 | 93 | 3.3% |
| Consulting Fee | $2,115 | 2 | 2.5% |
| Education | $374.60 | 16 | 0.4% |
| Travel and Lodging | $182.92 | 2 | 0.2% |
Payments by Type
Research
$73,626
11 transactions
General
$12,559
119 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $71,947 | 9 | $0 (2017) |
| CSL Behring | $7,658 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,870 | 20 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $1,804 | 3 | $0 (2017) |
| BioCryst Pharmaceuticals, Inc. | $875.00 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $391.08 | 9 | $0 (2024) |
| Genentech USA, Inc. | $231.15 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $186.78 | 6 | $0 (2017) |
| GENZYME CORPORATION | $172.79 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $158.28 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $681.55 | 24 | Genentech USA, Inc. ($171.66) |
| 2023 | $602.43 | 28 | AstraZeneca Pharmaceuticals LP ($100.02) |
| 2022 | $332.06 | 7 | Allergan, Inc. ($140.58) |
| 2021 | $44.71 | 3 | GlaxoSmithKline, LLC. ($30.78) |
| 2020 | $889.81 | 2 | BioCryst Pharmaceuticals, Inc. ($875.00) |
| 2019 | $136.50 | 4 | Regeneron Healthcare Solutions, Inc. ($97.40) |
| 2018 | $1,915 | 13 | Regeneron Healthcare Solutions, Inc. ($1,367) |
| 2017 | $81,583 | 49 | SANOFI US SERVICES INC. ($71,947) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Allergy and Immunology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $140.98 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Immunology | ||||||
| 07/29/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $86.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/01/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Immunology | ||||||
| 04/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Immunology | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $85.66 | General |
| Category: Respiratory | ||||||
| 04/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: Immunology | ||||||
| 02/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Education | In-kind items and services | $5.59 | General |
| Category: GENETIC DISEASE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study | SANOFI US SERVICES INC. | $50,536 | 3 |
| A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma | SANOFI US SERVICES INC. | $21,411 | 6 |
| An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment | Circassia Pharmaceuticals Inc | $1,679 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 422 | 4,920 | $227,272 | $109,658 |
| 2022 | 11 | 333 | 4,437 | $190,806 | $90,237 |
| 2021 | 10 | 303 | 4,382 | $181,791 | $89,735 |
| 2020 | 10 | 313 | 2,947 | $122,419 | $39,812 |
Total Patients
1,371
Total Services
16,686
Medicare Billing
$329,443
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 13 | 2,187 | $90,810 | $65,786 | 72.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 39 | 1,207 | $39,583 | $14,222 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 101 | $24,619 | $8,650 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 116 | $19,879 | $7,387 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $10,930 | $3,274 | 30.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 32 | 374 | $13,464 | $3,265 | 24.3% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 27 | 280 | $7,840 | $2,230 | 28.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 26 | 451 | $7,310 | $1,383 | 18.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,590 | $1,364 | 29.7% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 24 | 28 | $2,410 | $800.50 | 33.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 70 | $3,594 | $734.58 | 20.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 30 | 35 | $1,642 | $515.72 | 31.4% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 17 | 20 | $600.00 | $46.00 | 7.7% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 14 | 1,576 | $62,400 | $46,396 | 74.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 50 | 1,489 | $47,648 | $18,636 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 93 | $21,205 | $8,267 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 104 | $15,940 | $6,301 | 39.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 34 | 470 | $16,920 | $3,805 | 22.5% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 25 | 348 | $9,744 | $2,499 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $8,110 | $2,128 | 26.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 15 | 238 | $3,415 | $795.03 | 23.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 61 | $3,132 | $588.24 | 18.8% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 14 | 17 | $1,463 | $547.19 | 37.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 14 | 18 | $829.08 | $275.16 | 33.2% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2021 | 13 | 1,544 | $61,200 | $46,295 | 75.6% |
About Dr. James Baker, MD
Dr. James Baker, MD is a Specialist healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710982293.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Baker, MD has received a total of $86,185 in payments from pharmaceutical and medical device companies, with $681.55 received in 2024. These payments were reported across 130 transactions from 26 companies. The most common payment nature is "" ($73,626).
As a Medicare-enrolled provider, Baker has provided services to 1,371 Medicare beneficiaries, totaling 16,686 services with total Medicare billing of $329,443. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Allergy & Immunology, Allergy
- Location Portland, OR
- Active Since 06/20/2005
- Last Updated 07/28/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1710982293
Products in Payments
- SAR231893 (Drug) $71,947
- Haegarda (Biological) $7,550
- DUPIXENT DUPILUMAB INJECTION (Biological) $1,504
- DUPIXENT (Biological) $528.54
- Xolair (Biological) $231.15
- FASENRA (Biological) $165.42
- FASENRA (Drug) $159.19
- CINQAIR (Drug) $141.89
- BOTOX (Biological) $140.58
- NIOX VERO DEVICE (Device) $125.00
- NUCALA (Biological) $117.50
- TAKHZYRO (Biological) $113.08
- AYVAKIT (Drug) $95.49
- Berinert 500U (Biological) $91.05
- ALAIR (Device) $76.00
- CINRYZE (Drug) $75.30
- CUVITRU (Biological) $60.70
- EUCRISA (Drug) $54.39
- TRELEGY ELLIPTA (Drug) $40.78
- RINVOQ (Biological) $33.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Portland
Paul Duwelius, Md, MD
Specialist — Payments: $689,812
Specialist $689,812
Dr. Darrell Brett, M.d, M.D
Specialist — Payments: $340,657
Specialist $340,657
Dr. Jonathan Musmand, Md, MD
Specialist — Payments: $171,729
Specialist $171,729
Dr. Phoebe Rich, Md, MD
Specialist — Payments: $148,536
Specialist $148,536
Dr. Douglas Beaman, Md, MD
Specialist — Payments: $111,928
Specialist $111,928
Jay Butler, Md, MD
Specialist — Payments: $103,179
Specialist $103,179